Nicholas Plugis
Senior Principal at Flagship Pioneering
Cambridge, Massachusetts
Overview
Work Experience
Senior Principal
2023 - Current
Principal
2020 - 2023
Senior Associate
2018 - 2020
Associate
2017 - 2018
Consultant
2016 - 2017
VentureLabs Fellow
2016 - 2016
Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.
Advisor
2022
Founding Team, Chief Innovation Officer
2017 - 2022
Cellarity develops novel medicines that are unreachable with traditional methods of drug discovery, completely revolutionizing the way drugs are created.
Cellarity is a therapeutics company that uses genomic technologies, data science, and AI to develop a new generation of therapies.
Raised $294,000,000.00 from Kyowa Kirin, Flagship Pioneering and Hanwha Impact Partners.
Advisor
2022 - 2023
Founding Team
2020 - 2022
Abiologics, Inc. is a privately held, early-stage biotechnology company on a mission to make biology better through chemistry. We are pioneering the development of a transformational new class of medicines that is unlocked by novel synthetic and computational technologies.
Founding Team
2021 - 2022
Ampersand Biomedicines enables a new way of designing programmable medicines that work precisely where needed in the body and nowhere else.
Founding Team
2017 - 2019
Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.
Raised $490,000,000.00 from BlackRock, Invus, Flagship Pioneering, T. Rowe Price, Federated Kaufmann Fund, Longevity Vision Fund, Fidelity and CPP Investments.
Founding Team
2017 - 2018
Ring Therapeutics is revolutionizing the gene therapy and nucleic acid medicine space by harnessing the most abundant and diverse member of the human commensal virome, anelloviruses.
Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.
Raised $253,500,000.00 from Altitude Life Science Ventures, Flagship Pioneering, UPMC Enterprises, CJ Investment, Partners Investment, T. Rowe Price, Alexandria Venture Investments, Invus and Kyowa Kirin.
Vice President
2015 - 2016
Scientific and Market Advising in the Life Sciences
Engagement Manager
2014 - 2015
Analyst
2013 - 2014
Research Assistant
2010 - 2011
Department of Chemistry and Biochemistry, Laboratory of Dr. James Larrabee
Research Assistant
2008 - 2009
Departments of Chemistry and Radiology, Laboratory of Dr. Peter Caravan
Revolutionizing imaging for the advancement of science and medicine.